Tasted masked veterinary solid compositions

Details for Australian Patent Application No. 2003218722 (hide)

Owner Novartis AG

Inventors Thoma, Hubert; Schote, Uwe Thomas; Isele, Ute

Agent Davies Collison Cave

Pub. Number AU-B-2003218722

PCT Number PCT/EP03/02446

PCT Pub. Number WO2003/075895

Priority 02005511.7 11.03.02 EP

Filing date 10 March 2003

Wipo publication date 22 September 2003

Acceptance publication date 31 August 2006

International Classifications

A61K 9/26 (2006.01) Medicinal preparations characterised by special physical form - Discrete particles in supporting matrix

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 02005511.7 11.03.02 EP

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003218722

31 August 2006 Application Accepted

  Published as AU-B-2003218722

4 January 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003218723-DEVICE AND METHOD FOR OPTOELECTRONICALLY IDENTIFYING THE DISPLACEMENT AND/OR POSITION OF AN OBJECT

2003218721-USE OF 8-PRENYLFLAVANONES FOR ANTI-ANGIOGENESIS THERAPY AND FOR FIBRINOLYTIC THERAPY